U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443514) titled 'Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma' on Feb. 11.
Brief Summary: This prospective, non-randomized diagnostic interventional study evaluates cognitive impairment in patients with diffuse large B-cell lymphoma (DLBCL) treated at the Institute of Oncology Ljubljana. Chemotherapy regimens are administered according to clinical indication and are not assigned by the study protocol.
The research intervention consists of structured neurocognitive assessments and biomarker analyses performed at predefined time points during treatment and follow-up. Cognitive function will be assessed at baseline, after the fi...